Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Veerman

Showing results (881-890 of 941) with videos related to

Pageof 95
Sort By:
European Journal of Human Genetics : EJHG|May 1, 1997
Somatic mosaicism in Fanconi anemia: molecular basis and clinical significanceJ R Lo Ten Foe, M L Kwee, M A Rooimans, et al.
Pediatric Blood & Cancer|July 20, 2022
Childhood acute lymphoblastic leukemia: Four years evaluation of protocols 2013 and 2016 in a single center in Indonesia, a lower-middle-income countrySutaryo Sutaryo, Pudjo Hagung Widjajanto, Sri Mulatsih, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 25, 2018
Analysis of current perioperative management with Haemate<sup>®</sup> P/Humate P<sup>®</sup> in von Willebrand disease: Identifying the need for personalized treatmentH C A M Hazendonk, J M Heijdra, N C B de Jager, et al.
Scientific Reports|February 4, 2026
Can evolutionary therapy be applied in non-small cell lung cancer?Laura R Jansén-Storbacka, Kailas S Honasoge, Eva Molnárová, et al.
Leukemia|October 12, 2007
Prognostic significance of molecular-cytogenetic abnormalities in pediatric T-ALL is not explained by immunophenotypic differencesM van Grotel, J P P Meijerink, E R van Wering, et al.
Clinical Drug Investigation|August 1, 2025
Memantine for the Treatment of Primary Negative Symptoms in Schizophrenia: A Meta-analysis of Randomized Controlled TrialsHoulin Hong, Jack Donlon, Martin Schaefer, et al.
Leukemia|June 1, 2002
BFM-oriented treatment for children with acute lymphoblastic leukemia without cranial irradiation and treatment reduction for standard risk patients: results of DCLSG protocol ALL-8 (1991-1996)W A Kamps, J P M Bökkerink, F G A J Hakvoort-Cammel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2011
Prospective study on incidence, risk factors, and long-term outcome of osteonecrosis in pediatric acute lymphoblastic leukemiaMariël L te Winkel, Rob Pieters, Wim C J Hop, et al.
Acta Reumatologica Portuguesa|August 16, 2011
Physiotherapy in rheumatoid arthritis: development of a practice guidelineE J Hurkmans, F J van der Giesen, H Bloo, et al.
Schizophrenia Bulletin|February 20, 2021
Simvastatin Augmentation for Patients With Early-Phase Schizophrenia-Spectrum Disorders: A Double-Blind, Randomized Placebo-Controlled TrialIris E Sommer, Shiral S Gangadin, Lot D de Witte, et al.
Pageof 95

Showing results (881-890 of 941) with videos related to

Sort By:
Pageof 95
European Journal of Human Genetics : EJHG|May 1, 1997
Somatic mosaicism in Fanconi anemia: molecular basis and clinical significanceJ R Lo Ten Foe, M L Kwee, M A Rooimans, et al.
Pediatric Blood & Cancer|July 20, 2022
Childhood acute lymphoblastic leukemia: Four years evaluation of protocols 2013 and 2016 in a single center in Indonesia, a lower-middle-income countrySutaryo Sutaryo, Pudjo Hagung Widjajanto, Sri Mulatsih, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 25, 2018
Analysis of current perioperative management with Haemate<sup>®</sup> P/Humate P<sup>®</sup> in von Willebrand disease: Identifying the need for personalized treatmentH C A M Hazendonk, J M Heijdra, N C B de Jager, et al.
Scientific Reports|February 4, 2026
Can evolutionary therapy be applied in non-small cell lung cancer?Laura R Jansén-Storbacka, Kailas S Honasoge, Eva Molnárová, et al.
Leukemia|October 12, 2007
Prognostic significance of molecular-cytogenetic abnormalities in pediatric T-ALL is not explained by immunophenotypic differencesM van Grotel, J P P Meijerink, E R van Wering, et al.
Clinical Drug Investigation|August 1, 2025
Memantine for the Treatment of Primary Negative Symptoms in Schizophrenia: A Meta-analysis of Randomized Controlled TrialsHoulin Hong, Jack Donlon, Martin Schaefer, et al.
Leukemia|June 1, 2002
BFM-oriented treatment for children with acute lymphoblastic leukemia without cranial irradiation and treatment reduction for standard risk patients: results of DCLSG protocol ALL-8 (1991-1996)W A Kamps, J P M Bökkerink, F G A J Hakvoort-Cammel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2011
Prospective study on incidence, risk factors, and long-term outcome of osteonecrosis in pediatric acute lymphoblastic leukemiaMariël L te Winkel, Rob Pieters, Wim C J Hop, et al.
Acta Reumatologica Portuguesa|August 16, 2011
Physiotherapy in rheumatoid arthritis: development of a practice guidelineE J Hurkmans, F J van der Giesen, H Bloo, et al.
Schizophrenia Bulletin|February 20, 2021
Simvastatin Augmentation for Patients With Early-Phase Schizophrenia-Spectrum Disorders: A Double-Blind, Randomized Placebo-Controlled TrialIris E Sommer, Shiral S Gangadin, Lot D de Witte, et al.
Pageof 95